Print Icon
 

Next Generation Proteomics Highlights

   
Dear Subscriber, 

We are excited to share the latest updates and news from and around Biognosys and our research services with you:

Our Vision and Mission for You to Discover

At Biognosys, we believe that we can dramatically improve human health by deciphering the biological complexity of diseases. By providing access to the proteome on all levels, we enable life science researchers and drug hunters to unlock true discoveries. When we look at the proteome differently, we envision a better world!

7 Truths About Mass Spectrometry Proteomics

Mass spectrometry has come a long way since it was invented in 1912. More than a century of innovation has taken this technology to an entirely new level. Yet, there are still many misconceptions. In this article, we collect the top 7 facts about mass spectrometry-based proteomics that you might not know.

Using the Power of Proteomics to Predict Immunotherapy Responses

This article from Labiotech.eu covers two studies from Biognosys and our collaborators presented at ESMO '22. It explores how our discovery proteomics technology generates valuable insights into potential biomarkers, alone or combined with transcriptomics or immunohistochemistry.

Immuno-oncology Biomarker Discovery Posters Now Available

Our two ESMO '22 posters in collaboration with University of Zurich, NeoGenomics, and Istituto Nazionale Tumori Fondazione G Pascale on immunotherapy biomarker discovery with TrueDiscovery™ are now available on our website.


Visit our website to learn more about how we can support your proteomics research, and stay tuned for more exciting news to come.

Best regards, 
The Biognosys Team
   
   


Can't read or view images? View in Browser

Not interested? Unsubscribe

No more? Opt Out from Organization


   
   
Twitter
LinkedIn
YouTube